{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:23Z","timestamp":1760144123215,"version":"build-2065373602"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue de Pneumologie Clinique"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pneumo.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T19:34:10Z","timestamp":1416512050000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Int\u00e9r\u00eats des explorations fonctionnelles respiratoires et des \u00e9tudes des biomarqueurs dans le diagnostic et le suivi \u00e9volutif de la pneumopathie interstitielle diffuse dans la scl\u00e9rodermie syst\u00e9mique"],"prefix":"10.1016","volume":"70","author":[{"given":"T.","family":"Hua-Huy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.P.","family":"Tiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Dinh-Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneumo.2014.09.003_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-1-200401060-00010","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0010","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1378\/chest.84.5.546","article-title":"Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma","volume":"84","author":"Owens","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","article-title":"Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography","volume":"176","author":"Schurawitzki","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2008.091710","article-title":"Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study","volume":"68","author":"Vonk","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1259\/0007-1285-65-779-983","article-title":"Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis","volume":"65","author":"Garber","year":"1992","journal-title":"Br J Radiol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0040","first-page":"258","article-title":"Interstitial lung disease in systemic sclerosis","volume":"44","author":"Ooi","year":"2003","journal-title":"Acta Radiol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1378\/chest.54.6.490","article-title":"Pulmonary scleroderma","volume":"54","author":"Weaver","year":"1968","journal-title":"Dis Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0060","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0065","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1445-5994.2004.00674.x","article-title":"Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment","volume":"34","author":"Sahhar","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0070","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1093\/rheumatology\/kep109","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0080","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.1780370904","article-title":"Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0954-6111(89)80072-1","article-title":"Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc\u2013DTPA clearance","volume":"83","author":"Harrison","year":"1989","journal-title":"Respir Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005382-199203000-00005","article-title":"Pulmonary manifestations of scleroderma","volume":"7","author":"Arroliga","year":"1992","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/radiology.188.2.8327704","article-title":"Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage","volume":"188","author":"Remy-Jardin","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.200.2.8685321","article-title":"Glossary of terms for CT of the lungs: recommendations of the Nomenclature committee of the Fleischner Society","volume":"200","author":"Austin","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.2322031223","article-title":"CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia","volume":"232","author":"Desai","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thx.47.9.738","article-title":"High resolution computed tomography as a predictor of lung histology in systemic sclerosis","volume":"47","author":"Wells","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0120","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2214\/ajr.169.4.9308447","article-title":"Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring","volume":"169","author":"Kazerooni","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0125","first-page":"1789","article-title":"High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis","volume":"33","author":"Launay","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.bor.0000181534.67685.5a","article-title":"New developments in scleroderma interstitial lung disease","volume":"17","author":"Highland","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0135","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/rheumatology\/ken271","article-title":"High-resolution computed tomography and scleroderma lung disease","volume":"47","author":"Wells","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0140","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0145","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.127.1.171","article-title":"Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis","volume":"127","author":"King","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0155","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.22099","article-title":"Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline","volume":"55","author":"Plastiras","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/157339710791330768","article-title":"Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design","volume":"6","author":"Khanna","year":"2010","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00060209","article-title":"Prognostic factors for lung function in systemic sclerosis: prospective study of 105\u00a0cases","volume":"35","author":"Gilson","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1152\/jappl.1957.11.2.290","article-title":"Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries","volume":"11","author":"Roughton","year":"1957","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.1780350709","article-title":"Isolated diffusing capacity reduction in systemic sclerosis","volume":"35","author":"Steen","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.62.2.97","article-title":"Predictors of end stage lung disease in systemic sclerosis","volume":"62","author":"Steen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0190","first-page":"170","article-title":"Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease","volume":"18","author":"Chetta","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.06-0630","article-title":"Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients","volume":"131","author":"Villalba","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.080447","article-title":"Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma","volume":"36","author":"Garin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2006.054866","article-title":"Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test","volume":"66","author":"Buch","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0210","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2009.120303","article-title":"Validation of the 6min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group","volume":"69","author":"Avouac","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0215","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3899\/jrheum.081221","article-title":"Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis","volume":"36","author":"Schoindre","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semarthrit.2008.10.009","article-title":"Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature","volume":"40","author":"Kowal-Bielecka","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9343(90)90425-D","article-title":"Evaluation and management of scleroderma lung disease using bronchoalveolar lavage","volume":"88","author":"Silver","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0230","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0235","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1164\/ajrccm.150.2.8049830","article-title":"Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance","volume":"150","author":"Wells","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/ajrccm.154.2.8756813","article-title":"Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung","volume":"154","author":"Behr","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.58.10.635","article-title":"Pulmonary involvement in diffuse cutaneous systemic sclerosis: bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis","volume":"58","author":"Witt","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/rccm.200705-655OC","article-title":"Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease","volume":"177","author":"Strange","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0255","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/art.1780340406","article-title":"Eosinophil activation in systemic sclerosis","volume":"34","author":"Gustafsson","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0260","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1164\/ajrccm.157.5.9609096","article-title":"Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis","volume":"157","author":"Wells","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0265","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","article-title":"Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis","volume":"132","author":"White","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0270","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"Schmidt","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0275","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/arrd.1985.131.4.612","article-title":"Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis","volume":"131","author":"Rossi","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0889-857X(03)00025-5","article-title":"Interstitial lung disease in scleroderma","volume":"29","author":"White","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0285","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/ajrccm\/144.3_Pt_1.706","article-title":"Structural features of interstitial lung disease in systemic sclerosis","volume":"144","author":"Harrison","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0290","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0295","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.60.3.281","article-title":"Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis","volume":"60","author":"Fujita","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0300","first-page":"121","article-title":"The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia","volume":"19","author":"Kim","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0305","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.162.1.9903014","article-title":"Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis","volume":"162","author":"Takahashi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0315","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0320","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","article-title":"Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"44","author":"Asano","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1346-8138.2001.tb00013.x","article-title":"Surfactant protein D (SP-D) and systemic scleroderma (SSc)","volume":"28","author":"Maeda","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0330","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jbspin.2006.01.022","article-title":"Prognostic markers for systemic sclerosis","volume":"73","author":"Meyer","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/bmm.09.79","article-title":"Biomarkers in systemic sclerosis","volume":"4","author":"Castro","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0345","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jcp.20452","article-title":"CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity","volume":"206","author":"Luzina","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0350","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0355","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0360","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.22559","article-title":"CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis","volume":"56","author":"Prasse","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0365","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1183\/09031936.00004711","article-title":"Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis","volume":"38","author":"Tiev","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0370","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-004-0987-3","article-title":"Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement","volume":"24","author":"Kuryliszyn-Moskal","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0375","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u00a0\u2013\u00a0a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0380","first-page":"414","article-title":"Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato\/polymyositis","volume":"26","author":"Kum\u00e1novics","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0385","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1183\/09031936.97.10020280","article-title":"Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography","volume":"10","author":"Wells","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0390","first-page":"547","article-title":"Increased nitric oxide in exhaled air in patients with systemic sclerosis","volume":"16","author":"Fajac","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0395","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.52.12.1051","article-title":"Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension","volume":"52","author":"Kharitonov","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0400","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1378\/chest.115.5.1352","article-title":"Exhaled nitric oxide is increased in active fibrosing alveolitis","volume":"115","author":"Paredi","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0405","first-page":"1693","article-title":"Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension","volume":"27","author":"Rolla","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0410","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1378\/chest.119.5.1449","article-title":"Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease","volume":"119","author":"Moodley","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0415","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1152\/jappl.1998.85.2.653","article-title":"A two-compartment model of pulmonary nitric oxide exchange dynamics","volume":"85","author":"Tsoukias","year":"1998","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1183\/09031936.00129806","article-title":"Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide","volume":"30","author":"Tiev","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0425","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1164\/rccm.2104003","article-title":"Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease","volume":"165","author":"Girgis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0430","first-page":"S5","article-title":"Increased alveolar nitric oxide in early systemic sclerosis","volume":"28","author":"Wuttge","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0435","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.niox.2012.10.005","article-title":"High alveolar concentration of nitric oxide is associated with alveolitis in scleroderma","volume":"28","author":"Tiev","year":"2013","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0440","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.niox.2008.11.004","article-title":"Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis","volume":"20","author":"Tiev","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0445","first-page":"32","article-title":"Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis","volume":"26","author":"Tiev","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/thoraxjnl-2011-200499","article-title":"Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma","volume":"67","author":"Tiev","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0455","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3899\/jrheum.090915","article-title":"Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis","volume":"37","author":"Hua-Huy","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pneumo.2014.09.003_bib0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.niox.2014.04.011","article-title":"Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease","volume":"40","author":"Tiev","year":"2014","journal-title":"Nitric Oxide"}],"container-title":["Revue de Pneumologie Clinique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841714001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841714001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:16:18Z","timestamp":1760105778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761841714001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0761841714001199"],"URL":"https:\/\/doi.org\/10.1016\/j.pneumo.2014.09.003","relation":{},"ISSN":["0761-8417"],"issn-type":[{"type":"print","value":"0761-8417"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eats des explorations fonctionnelles respiratoires et des \u00e9tudes des biomarqueurs dans le diagnostic et le suivi \u00e9volutif de la pneumopathie interstitielle diffuse dans la scl\u00e9rodermie syst\u00e9mique","name":"articletitle","label":"Article Title"},{"value":"Revue de Pneumologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneumo.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}